Seeking Alpha

"The (pharmaceutical) industry needs to spend more money on R&D and less on sales and...

"The (pharmaceutical) industry needs to spend more money on R&D and less on sales and marketing, says Novartis (NVS +1.2%) CEO Joseph Jimenez. He also believes "that in the future, companies like Novartis are going to be paid on patient outcomes as opposed to selling the pill." However, Jimenez warns that price cuts, such as those in Europe, "create a disincentive for us to build sales force."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|